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A Raskovic14, R Regenthal15, EJ Sanz16, BI Tamba17, K Wilson18, TP de Vries1,2, MC Richir1,2,
MA van Agtmael1,2, on behalf of the Working Group Research on CPT Education of the European
Association for Clinical Pharmacology and Therapeutics (EACPT)
Europeanmedical students should have acquired adequate prescribing competencies before graduation, but it is not known
whether this is the case. In this international multicenter study, we evaluated the essential knowledge, skills, and attitudes in
clinical pharmacology and therapeutics (CPT) of final-year medical students across Europe. In a cross-sectional design, 26
medical schools from 17 European countries were asked to administer a standardized assessment and questionnaire to 50
final-year students. Although there were differences between schools, our results show an overall lack of essential prescribing
competencies among final-year students in Europe. Students had a poor knowledge of drug interactions and contraindica-
tions, and chose inappropriate therapies for common diseases or made prescribing errors. Our results suggest that under-
graduate teaching in CPT is inadequate inmany European schools, leading to incompetent prescribers and potentially unsafe
patient care. A European core curriculumwith clear learning outcomes and assessments should be urgently developed.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
 Previous studies have shown that recent medical graduates are
responsible for the majority of prescribing errors in clinical prac-
tice. Additionally, it has been reported that ﬁnal-year medical stu-
dents do not feel prepared for their prescribing task and lack
conﬁdence in prescribing.
WHAT QUESTION DID THIS STUDY ADDRESS?
 This international multicenter study evaluated the essential
clinical pharmacology and therapeutics (CPT) competencies
of ﬁnal-year medical students across Europe.
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE
 Undergraduate teaching in CPT is inadequate in many
European medical schools, leading to incompetent prescribers
and potentially unsafe patient care. Medical students
taught mainly with problem-based learning CPT curricula have
signiﬁcantly better prescribing competencies than students
taught mainly with traditional learning CPT curricula.
HOW THIS MIGHT CHANGE CLINICAL PHARMA-
COLOGY OR TRANSLATIONAL SCIENCE
 A European core curriculum in CPT should be developed
with clear learning outcomes, with emphasis on teaching
and gaining early experience in drug prescribing for patients
in a real-life clinical setting. There is a need for a robust
European assessment structure to ensure these outcomes are
met.
In most European countries, medical graduates enter directly into
clinical practice immediately after graduation and are required to
prescribe drugs on a daily basis. In order to prescribe safely and
effectively, graduates should have acquired a minimum set of pre-
scribing competencies (i.e., knowledge, skills, attitudes) by the
time they graduate. Although there is no uniform description of
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what this minimal set should be, the European Association of
Clinical Pharmacology and Therapeutics (EACPT) stated that
European graduates should have sufﬁcient knowledge of com-
monly prescribed drugs, the ability to adequately treat the most
common diseases, a rational approach to drug selection, and the
ability to write a prescription safely and unambiguously.1 Unfor-
tunately, ﬁndings suggest that European medical graduates do
not possess these minimum competencies, because they feel
unprepared for their future prescribing task and have little conﬁ-
dence in their prescribing competencies.2–4 Moreover, prescribing
errors are common in hospitals, with one review reporting that
errors occurred in about 7% of hospital prescriptions, 2% of
patient days, and 50% of hospital admissions.5 A large UK study
found a prescription error rate of 8.9% for all medication orders,2
with junior doctors (Foundation Years 1 and 2) being twice as
likely as consultants to make a prescribing error. This is even
more worrying given that junior doctors write a large proportion
of hospital prescriptions.2
Poor undergraduate teaching in pharmacology and clinical
pharmacology and therapeutics (CPT) may underlie this lack of
prescribing competencies,2 although there are marked differences
in the quantity and quality of CPT education within and
between European countries.1,6,7 This emphasizes the need for a
uniform core curriculum in CPT for European medical schools,
as suggested by the EACPT in 2007.1 However, much of the
available information that could form the basis for curriculum
development is out of date, mainly based on expert opinion, and
lack supporting quantitative data.8–11 To gain insight into the
level of essential CPT knowledge, skills, and attitudes of ﬁnal-
year medical students, in order to highlight gaps in knowledge
and competence, and to serve as a baseline evaluation for further
investigations, we carried out an international multicenter study
involving ﬁnal-year medical students in several European medical
schools. Based on the available literature, we hypothesized that
the prescribing competencies of ﬁnal-year medical students in
Europe are insufﬁcient to prescribe safely and effectively after
graduation.
RESULTS
Between 1 March 2015 and 31 March 2016, 17 medical schools
(65%; 17/26) from 15 European countries provided data for 895
ﬁnal-year students (Figure 1). Three of these medical schools
included ﬁnal-year and penultimate-year students, but as there
were no relevant differences in demographics and assessment
scores (maximum difference 0.6 SD) between these groups in all
medical schools, the data for these students were included for
analysis.
Knowledge and skills
Students’ overall knowledge score was 69.6% (SD 14.9), with the
lowest score (50.0%; SD 20.9) being for interactions and contrain-
dications (Table 1). Overall, 46.2% (range 15–76) of the therapies
were inappropriate and 54.7% (range 34–65) of the prescriptions
contained one or more prescribing errors. The most common errors
Invited: 26 medical schools, 17 European countries (BE, CZ, DE, EE, EL,
ES, FR, HR, HU, IT, LT, NL, PT, RO, RS, SE, UK)
8 schools excluded:
6 could not conduct the 
assesment in time
2 did not respond in time
Participated: 18 medical schools, 15 European countries (BE, DE, EE,
EL, ES, FR, HR, IT, LT, NL, PT, RO, RS, SE, UK)
1 school with 4 participating
students was excluded 
Included: 17 medical schools, 15 European countries (right):
- 8 mainly TL, 6 mainy PBL, 3 ML CPT curriculum
- duration medical curriculum: range 5–7 year
- 895 final-year students
- average number students per school: 52.6 (range
20–222)
- median age: 24 (range 21–43)
- 61.0% female
- 98.1% European nationality
BE, Belgium; CZ, Czech Republic; DE, Germany; EE, Estonia; EL, Greece;
ES, Spain; FR, France; HR, Croatia; HU, Hungary; IT, Italy; LT, Lithuania;
NL, Netherlands; PT, Portugal; RO, Romania, RS, Serbia; SE, Sweden;
UK, United Kingdom. TL, traditional learning, PBL, problem-based learning,
ML, mixed learning, CPT, clinical pharmacology and therapeutics.
Figure 1 Left: Study flow diagram. Right: Map of the number of included medical schools by country.
ARTICLES
282 VOLUME 101 NUMBER 2 | FEBRUARY 2017 | www.wileyonlinelibrary/cpt
were “less effective drug choice” (19.6%), “incomplete/incorrect
drug prescription” (18.0%), and “overdosing” (17.9%).
Attitudes
Few students felt conﬁdent about their prescribing skills (Figure 2).
In total, 70% (range 19–93) of the students reported that they had
“written/typed a drug prescription during undergraduate study”
10 or fewer times, of whom 45% (range 0–72) had never written
out a prescription. Students estimated they spent most study hours
on self-directed learning (201 hours) and lectures and seminars
(78 hours), and the least on computer-based teaching and eLearn-
ing (13 hours) and individual teaching with the supervisor (22
hours) (Figure 3). Most students (>60%) were not satisﬁed about
the undergraduate teaching in clinical pharmacology and pharma-
cotherapy they had received and thought that too little time was
devoted to these subjects (Figure 4a,b). Most students (61%) felt
conﬁdent about ﬁnding relevant drug information to support pre-
scribing. Forty-one percent of the students felt that their medical
curriculum had not adequately prepared them for their future pre-
scribing responsibilities as junior doctor, 30% were neutral, and
only 29% thought they were adequately prepared.
Associations
Students taught mainly with problem-based learning or mixed
learning CPT curricula had signiﬁcantly higher overall knowledge
scores than students taught mainly with traditional learning cur-
ricula (16.8%; 95% conﬁdence interval (CI) 4.6 to 9.0; P <
0.001, and 13.9 %; 95% CI 1.0 to 7.0; P < 0.05, respectively)
and a signiﬁcantly lower rate of inappropriate therapies (229.4%;
95% CI –22.7 to –35.5; P < 0.001, and –14.7%; 95% CI –2.9 to
–25.1; P < 0.05, respectively). Students who had written more
than 10 prescriptions as undergraduates had signiﬁcantly lower
rates of inappropriate drug prescribing than those who had writ-
ten fewer than 10 prescriptions (–8.9%; 95% CI –0.7 to –16.5;
P < 0.05). For each point increase on the Likert scale of prescrib-
ing conﬁdence, the rate of inappropriate drug prescribing signiﬁ-
cantly decreased by 12.9% (95% CI –7.0 to –18.4; P < 0.001).
DISCUSSION
Although there were differences between medical schools, our
results show an overall lack of essential prescribing competencies
among ﬁnal-year medical students in 15 European countries. In
particular, the students had a poor knowledge of drug interac-
tions and contraindications, and chose inappropriate therapies
for common diseases (46%) or made prescribing errors (55%).
Students taught mainly with problem-based learning or mixed
learning CPT curricula had signiﬁcantly better knowledge (17
and 14%, respectively) and chose fewer inappropriate therapies
(–29% and –15%, respectively) than students taught mainly with
traditional CPT curricula. Overall, students lacked conﬁdence
about essential prescribing skills, and most were not satisﬁed
about the quantity and quality of undergraduate teaching in clini-
cal pharmacology and pharmacotherapy they had received. Only
29% of the students felt adequately prepared for their future pre-
scribing task as doctors. These ﬁndings suggest that undergradu-
ate teaching in CPT in European medical schools may fail to
provide newly qualiﬁed doctors with sufﬁcient prescribing com-
petencies, which has potential consequences for patient care and
treatment effectiveness.
Limitations
The study had a number of limitations. First, the sample repre-
sented only a small proportion of the ﬁnal-year students in each
school and thus ﬁndings about prescribing competencies cannot
necessarily be extrapolated to the whole cohort. Second, the use
of English for the assessment could have introduced bias, because
Table 1 Essential knowledge and skills in clinical pharmacology
and therapeutics of European final-year students (n 5 895).
Knowledge (MCQsa)
Pharmacological mechanisms of actionb % (SD) 79.3 (18.1)
Side effectsb % (SD) 79.4 (17.7)
Interactions and contraindicationsb % (SD) 50.0 (20.9)
Totalb % (SD) 69.6 (14.9)
Skills (clinical case scenarios)
Total number of therapies n 4.195
Appropriatec % (range) 26.2 (5–52)
Suboptimalc % (range) 27.6 (15–40)
Inappropriatec % (range) 46.2 (15–76)
- Not immediately harmful % (range) 81.1 (63–100)
- Potentially harmful % (range) 15.2 (0–35)
- Potentially lethal % (range) 3.7 (0–13)
Total number of prescriptions n 5.429
Total number of prescribing errors n 5.104
Number of prescriptions including errors n (%) 2.771 (54.7)
Type of errorsd
- Not indicated/inappropriate for indication % 9.1
- Less effective drug choice % 19.6
- Underdosing % 7.8
- Overdosing % 17.9
- Too short duration % 5.5
- Too long duration % 11.3
- Incorrect route % 1.4
- Incomplete/incorrect drug prescription % 18.0
- Protecting/preventing medication omitted % 3.0
- Drug group name % 2.3
- Inappropriate abbreviation % 0.9
- Therapeutic duplicity % 0.7
- Other % 2.5
aMCQs, multiple-choice questions. bPercent of the total maximum score with equal
weighting per medical school. cPercent of the total number of drug therapies with
equal weighting per school. dPercent of the total number of prescribing errors with
equal weighting per school.
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this increased the difﬁculty of the assessment for nonnative
English-speaking students; however, only nine students (1%) con-
sidered the use of English an obstacle (data not shown). Third,
the inaccessibility of decision-support facilities, such as formular-
ies and guidelines, during the assessment does not reﬂect clinical
practice, but we investigated knowledge and skills that European
graduates should intrinsically possess without having to resort to
guidelines or standards. Fourth, the study was carried out during
the ﬁnal year, and so results may underestimate prescribing com-
petence at the end of the year. However, it is unlikely that stu-
dents signiﬁcantly improved their competence in the remaining
months, because in most medical schools clinical prescribing train-
ing is not trained during this period. Fifth, there may have been
selection bias, with participating students being more conscientious
than average students or more likely to participate (students were
selected by the local study coordinator), or participating medical
schools connected to the EACPT Network of Teachers in Phar-
macotherapy might devote more hours to CPT education than
nonparticipating medical schools. However, in all cases competen-
cies would probably have been overestimated. Sixth, since seven
coordinators organized multiple sessions, we cannot rule out that
some students told fellow students about the assessments, although
they were speciﬁcally instructed not to do so. Lastly, because the
assessment was performed in a controlled setting, it can be ques-
tioned whether the same results would be found in clinical prac-
tice. However, it is unlikely that competence would be better in
clinical practice, given the time pressure, stress, and distractions on
hospital wards.
Interpretation of results
Our ﬁndings suggest that European ﬁnal-year medical students
do not have the required level of prescribing competencies, as
deﬁned by the EACPT.1 Although a gold standard for sufﬁcient
knowledge is not available, we believe, in line with the UK Pre-
scribing Safety Assessment,12 that medical graduates should have
high test scores (80–90%) to be able to prescribe safely and
effectively after graduation. In particular, students had a poor
knowledge of drug interactions and contraindications (50%), as
also reported for junior and senior doctors.13 This poor knowl-
edge could be because the quantity and quality of undergraduate
clinical pharmacology teaching is inadequate, as implied by the
students. Despite the growing digital support (e.g., apps, web-
sites), clinical pharmacology remains a target for educational
improvement, because an adequate knowledge of drug
0% 25% 50% 75% 100%
Step 6: Determine monitoring parameters
Step 5b: Give information and instructions
Step 5a: Write prescription 
Step 4c: Calculate the correct drug dose
Step 4b: Choose the correct dose and interval
Step 4a: Choose a (drug) treatment 
Step 3b: Verify the suitability 
Step 3a: Specify standard treatment 
Step 2: Specify therapeutic objective 
Step 1: Define indication
Neutral
Confident - Very confident
Unconfident - Very unconfident 
Figure 2 Self-reported confidence in prescribing skills according to WHO 6-step method (n 5 895).
Figure 3 The median number of estimated hours devoted to various methods to teach clinical pharmacology and therapeutics during undergraduate cur-
ricula (interquartile range and 10–90 percentiles shown).
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interactions and contraindications, especially of commonly pre-
scribed drugs, remains crucial to prescribe safely and to minimize
the risk of harm to patients.14
Nearly half of the therapies (46%) were inappropriate, with a
substantial proportion of these being potentially harmful (15%)
or potentially lethal (4%). This is worrying because the clinical
cases were based on common diseases that European graduates
will encounter regularly in daily practice. Although this is the ﬁrst
European multicenter study, similar deﬁcits in prescribing skills
have been observed in smaller local studies in the past.15–17
Together with our results, this implies that the level of prescrib-
ing skills of European graduates remains insufﬁcient and has not
substantially improved over the last few years. The students’
opinions about their education suggest that the lack of prescrib-
ing skills is because of inadequate undergraduate pharmacothera-
py teaching.
The number of erroneous prescriptions (55%) was higher than
that reported in a UK study (44%).17 This high rate is perhaps not
surprising, since 70% of the European students had written fewer
than 10 drug prescriptions during their medical training. Gaining
experience in writing drug prescriptions may be an important area
for curriculum improvement, because “experienced” students made
signiﬁcantly fewer inappropriate drug prescriptions. Subanalysis
showed that one of the main factors inﬂuencing prescribing experi-
ence is curriculum type: 54% of the students taught mainly with
problem-based learning curricula had written fewer than 10 pre-
scriptions compared with 78% of the students taught mainly with
traditional-based learning curricula. Problem-based learning curric-
ula may put more emphasis on writing prescriptions during clinical
clerkships.
Although in practice most prescribing errors are intercepted by
pharmacists and nurses before they cause harm,2 the high error
rate may have implications for patient safety. The most common
type of error was “less effective drug choice,” i.e., the prescription
of an inferior drug for an indication. This might be because med-
ical curricula do not emphasize the use of European and national
guidelines for the treatment of common diseases. Dosage errors
and incomplete drug prescriptions were also common, which is
in line with previous studies among junior doctors.2,5
One could argue that the prescribing knowledge and skills
assessed in this study are appropriate for a generalist (e.g., general
practitioner) rather than a specialist (e.g., urologist) medical pro-
fessional. The latter would undergo additional subspecialty
training to acquire the relevant knowledge and skills that are
domain-speciﬁc. However, we believe, in line with the EACPT
criteria,1 that medical graduates should have broad-based knowl-
edge and skills in CPT in order to prescribe safely and effectively
once qualiﬁed, regardless of their future specialty. Moreover, one
could ask whether it is essential to have knowledge and skills
because electronic prescribing systems alert healthcare professio-
nals to potentially harmful drug combinations and contraindica-
tions. However, not all of prescribing systems perform well or
consistently and many provide a high volume of irrelevant drug
safety alerts, which could lead to “alert fatigue.”18 Moreover, in
clinical practice doctors do not always refer to relevant prescrib-
ing guidelines, because they are missing, out of date, or too volu-
minous. Prescribing in these or acute situations is a reason why
doctors should have ready knowledge and a broad skills set.
As reported earlier, we found that ﬁnal-year medical students
did not feel conﬁdent about essential prescribing skills.4,19,20 In
particular, they lacked conﬁdence in how to calculate doses and
how to choose the right dose and interval of administration,
probably because many students had had little practice in pre-
scribing. In contrast to our previous study, in which we found
conﬁdence to be poorly correlated with assessed prescribing
skills,19 we found prescribing conﬁdence to be signiﬁcantly associ-
ated with less inappropriate drug prescribing (–13% per point
increase). This difference might be because of the different meth-
ods used to assess prescribing skills (i.e., oral vs. written assess-
ment). However, this ﬁnding, together with the fact that a lack
of self-conﬁdence is undesirable for students’ professional devel-
opment,20 indicates that graduates need to feel conﬁdent in their
0% 25% 50% 75% 100%
Pharmacotherapy
Clinical pharmacology
Basic pharmacology
Average
Good - Very Good
B
Poor - Very Poor
0% 25% 50% 75% 100%
Pharmacotherapy
Clinical pharmacology
Basic pharmacology
Just about right
Too much - Far too much
A
Too little - Far too little
Figure 4 Amount (a) and rating (b) of basic pharmacology, clinical pharmacology, and pharmacotherapy teaching in undergraduate medical curricula.
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prescribing competence in order to cope with the demanding
task of prescribing.
Although students’ familiarity with a “problem-based” assess-
ment method could have inﬂuenced results, to our knowledge
this is the largest study to show that students taught mainly with
problem-based learning curricula have considerably better pre-
scribing knowledge and skills than students taught mainly with
traditional CPT curricula. Since nearly half of the participating
medical schools (n 5 8; 47%) have traditional CPT curricula,
curricular changes might be appropriate, especially since students
spent most study hours on passive activities (e.g., learning and lis-
tening) and very few on active activities (e.g., clinical prescribing).
These ﬁndings are similar to the results of a study among 30
medical schools in the UK.6 Although curricular change is a slow
and demanding process, it is essential in order to increase the pre-
scribing competencies of future European doctors.
CONCLUSIONS AND RECOMMENDATIONS
This is the ﬁrst international multicenter study to report an over-
all lack of essential prescribing competencies among European
ﬁnal-year medical students. These results are disturbing. To
redress the situation, we suggest the following: 1) a European
CPT curriculum should be developed with clear learning out-
comes, emphasis on gaining early experience of drug prescribing
for real patients in a clinical setting and completing prescriptions;
2) a robust European assessment structure (“European Prescrib-
ing License”) should be set up to ensure these outcomes are met;
3) best practices and teaching materials in CPT should be shared
among European medical schools; and 4) CPT education should
be continued during postgraduate training.
METHODS
Study design and participants
In this descriptive, cross-sectional study, 26 medical schools in 17 Euro-
pean countries administered a standardized assessment and questionnaire
to a sample of their ﬁnal-year medical students (Figure 1). Medical
schools connected to the EACPT Network of Teachers in Pharmaco-
therapy (NOTIP) were invited to participate. NOTIP is a European
platform for medical schools and CPT teachers who develop and share
teaching materials and participate in joint research projects. A minimum
sample size of 36 students per school was required, assuming that 90% of
students would have an assessment score of 90% or higher, and a stan-
dard error of 0.05. The ﬁnal-year students were expected to graduate
within 1 year. Students were included only if they had followed the
undergraduate CPT program at their medical school. The Dutch Ethics
Review Board of Medical Education approved the study (Approved
Project no. NVMO-ERB 457). Further approval in other countries was
not necessary. All participants gave their informed consent.
Assessment tool and questionnaire: design
Based on the minimal set of prescribing competencies deﬁned by
EACPT,1 a Web-based assessment tool and questionnaire (in English)
were developed by the participating centers. The tool consisted of 24
multiple-choice questions (MCQs, knowledge) and ﬁve clinical case sce-
narios (skills). The MCQs covered basic pharmacological mechanisms of
action (n 5 8), drug side effects (n 5 8), drug–drug interactions, and
drug–disease contraindications (n 5 8) of essential drug(s), as listed in
the World Health Organization (WHO) list of essential medicines.21
The questions about the clinical case scenarios assessed essential
CPT knowledge, that is, ready knowledge in CPT that every medical
graduate should have acquired before graduation (example: Supplemental
Figure 1).14
The scenarios described diseases selected from the list of 40 core dis-
eases that European medical graduates should know how to treat, name-
ly, acute bronchitis, gastroesophageal reﬂux disease, community-acquired
pneumonia, osteoarthritis, essential hypertension (example: Supplemen-
tal Figure 2).8 Scenarios were presented in the same format,22 but dif-
fered in complexity (disease severity and complicating factors, such as
age, comorbidity, and comedication). For each case, the student could
choose to prescribe a new drug (maximum of two per case), not to pre-
scribe a drug, and/or stop comedication. Prescribing a new drug meant
that the student had to complete an electronic prescription form, includ-
ing drug name, dose, dosage, duration of treatment, and route of
administration.
A standardized questionnaire (attitudes), based on the literature and
our previous work (Supplemental Figure 3),3,4,6,19,20 asked about demo-
graphics, self-reported conﬁdence in prescribing skills (WHO 6-step23),
estimated number of drugs prescribed, estimated number of study hours,
evaluation of CPT education received, and perceived preparedness for
prescribing. The heads of undergraduate CPT education (local coordina-
tors) indicated the type of CPT curriculum at their medical school
(Table 2).
Assessment tool and questionnaire: validity and reliability
The face and content validity of the assessment and questionnaire were
established during two online modiﬁcation rounds with an expert panel
of 10 local coordinators. MCQs were based on example questions and
ﬁnal attainment levels of the Dutch National Pharmacotherapy Assess-
ment, which assesses the essential prescribing knowledge of ﬁnal-year
medical students.24 Minor modiﬁcations to the content were made on
the basis of a pilot test with 20 medical students from one medical
school (Netherlands). The construct validity of the MCQs was based on
the scores of clinical pharmacologists/internists not otherwise involved
in the study (one from each participating country). With an average
score of 91.4% (standard deviation (SD) 6.6), the MCQs evaluated
knowledge known by European experts. The internal consistency of the
MCQs was good (Guttman Lambda 2 of 0.70).25 The P-values (percent
of correctly answered questions) for individual questions ranged from
0.25 to 0.95, indicating a good spread of difﬁculty. The item-rest
Table 2 Types of curriculum for clinical pharmacology and therapeutics
Type Description
Mainly traditional learning curriculum >50% of education consists of one or more of the following: lectures
(formal), self-directed learning (textbooks), oral and written exams, essays
Mainly problem-based learning curriculum >50% of education consists of one or more of the following: seminars
(interactive), small working groups (case scenarios), role playing and
patient simulation including OSCEs, clinics including prescribing for real
patients
Mixed learning curriculum Equal mixture (50/50%) of traditional learning and problem-based learning
OSCE, Objective Structured Clinical Examination.
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Table 3 Marking scheme adapted from the EQUIP classification scheme including examples of drug therapies prescribed by
students
Category Subcategory Description Examples (related clinical case)
Appropriate  A drug therapy is defined as appropriate if the correct drug,
dose, dosage, duration, and route is chosen according to the
European and/or local guidelines
 amoxicillin 500mg three times a
day for 5 days per os (CAPa)
Suboptimal  The dose of drug therapy is slightly too high (half to two times
the normal dose) for the condition being treated
 esomeprazole 40mg once daily
(GERDb)
 The dose of drug therapy is slightly too low for the condition
being treated to produce the desired outcome
 paracetamol 1000mg twice daily
(osteoarthritisc)
 The duration of drug therapy is slightly too long for the
condition being treated
 amoxicillin 14 days therapy (CAP)
 The duration of drug therapy is slightly too short for the
condition being treated to produce the desired outcome
 omeprazole 3 weeks (GERD)
 Second or third choice of drug is prescribed instead of
first-choice drug for the condition being treated (according to
the local or (inter)national guidelines)
 ranitidine instead of omeprazole
(GERD)
 Symptomatic drug therapy is prescribed without strong
scientific benefits for the patient
 acetylcysteine (bronchitisd)
Inappropriate Not immediately
harmful
 The drug dose is too high (three times to four times the
normal dose) for the condition being treated
 enalapril 20 mg once daily
(hypertensione)
 The drug dose is too low for the condition being treated to
expect a beneficial outcome
 amoxicillin 375mg once daily (CAP)
 The duration of the drug therapy is too long for the condition
being treated resulting in drug overuse
 omeprazole life-long (GERD)
 The duration of the drug therapy is too short for the condition
being treated to produce the desired outcome
 valsartan 1 week (hypertension)
 Incorrect drug formulation for route of drug administration  ceftriaxone per os (CAP)
 No drug therapy is prescribed although the condition requires
initiation of drug therapy
 no additional analgesic prescribed
(osteoarthritis)
 Omission of protective or preventive drug therapy  NSAID without PPI (osteoarthritis)
 Unnecessary drug therapy is prescribed for which there is no
valid medical indication
 amoxicillin (bronchitis)
 Duplicate drug therapy is prescribed without benefits for the
patient
 two times salbutamol (bronchitis)
 The prescription lacked drug name, dose, dosage, duration,
route, or included inappropriate abbreviations, or drug class
instead of generic name, or was illegible
 ‘PPI’ (GERD)
Potentially
harmful
 The drug dose is too high (four to ten times the normal dose)
for the condition being treated with increased risk of adverse
effects
 tramadol 500 mg once daily
(osteoarthritis)
 Unnecessary drug therapy is prescribed for which there is no
valid medical indication and with increased risk of adverse
effects
 amitriptyline (osteoarthritis)
 Intravenous drug therapy is prescribed while not medically
necessary
 ceftriaxone intravenous (CAP)
 Duplicate drug therapy is prescribed with increased risk of
adverse effects
 two times ibuprofen (osteoarthritis)
 Drug therapy could exacerbate the patient’s condition
including drug-drug interaction or drug-disease contraindication
 propranolol and asthma
(hypertension)
Table 3 Continued on next page
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correlations (rir) for all questions were positive, so no questions were
excluded from analyses.
Data collection
The local coordinator selected a random sample of ﬁnal-year medical stu-
dents who would graduate within a year. Recruitment was done during
regular teaching sessions, by email, and/or with announcements on elec-
tronic notice boards. Selected students were asked to complete the assess-
ment and questionnaire within 60 minutes in a computer room at a
scheduled time under the supervision of a local teacher. Seven coordina-
tors organized more than one session to recruit students; information
exchange between peers was explicitly prohibited. At the start of the
assessment, students were informed about the study objective and
received instructions. They were not allowed to use references (except an
English dictionary) or to consult each other, or the supervisor. Participa-
tion was voluntary, anonymous, and without consequences to prevent
test-driven learning prior to the assessment.
Scoring
All MCQs were scored as right or wrong (1–0). Scores are expressed as a
percentage of the maximum score. The scoring scheme for the clinical
cases was developed by participating coordinators and was based on cor-
responding European guidelines26–29 adjusted for local practice
(Table 3).2 For each case, the choice of therapy (i.e., newly prescribed
drug or no drug, and/or stopped comedication) was classiﬁed as appro-
priate, suboptimal, or inappropriate by the main researcher (D.B.). In
case of doubt, a second person was consulted (T.S.). If there was dis-
agreement, the topic was discussed until consensus was reached. To assess
interrater reliability, a third assessor (J.T.) scored a purposive sample of
100 drug choices. The proportion of absolute agreement and kappa coef-
ﬁcient between D.B. and J.T. were 89% and 0.85, respectively, indicating
substantial agreement.30 Lastly, students’ prescriptions were screened by
D.B. for prescribing errors, as deﬁned by Dean et al.,31 and categorized
by type (Table 1).2
Statistical analysis
Weighting was used to ensure that each medical school had the same
inﬂuence in the descriptive analyses. Linear regression analysis was used
to compare overall knowledge scores by curriculum type. A Poisson
regression model was used to analyze whether curriculum type, number
of drugs prescribed, and overall self-reported conﬁdence in prescribing
skills were associated with different rates of inappropriate therapy (i.e.,
not immediately harmful, potentially harmful, and potentially lethal).
Data were collected and analyzed using SPSS v. 22.0 (Chicago, IL).
Additional Supporting Information may be found in the online version of
this article.
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